Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Emalex Biosciences (0) Acquired (1)
ecopipam (16 trials)
Key: Emalex Biosciences (3) Acquired (1)
mefenamic acid (ponstel) (1 trial)
moxifloxacin (avelox) (1 trial)
rifampin (1 trial)
valproic acid (depakene) (1 trial)
Childhood-Onset Fluency Disorder (Phase 2)
Stuttering (Phase 2)
Syndrome (Phase 2)
Tourette Syndrome (Phase 2)
Trials (17 total)
Trial APIs (5 total)